Douglas A Jabs Selected Research

Scleritis (Episcleritis)

1/2022	Scleritis in Lyme Disease.
1/2022	Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.
1/2021	Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive Factors.
3/2014	Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
10/2012	Regional corticosteroids for scleritis.
3/2010	Mycophenolate mofetil for ocular inflammation.
11/2009	Methotrexate for ocular inflammatory diseases.
10/2009	Azathioprine for ocular inflammatory diseases.
10/2008	Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
8/2005	Mycophenolate mofetil therapy for inflammatory eye disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas A Jabs Research Topics

Disease

45	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2002
41	Uveitis 04/2022 - 08/2002
38	Retinitis 01/2019 - 04/2002
33	Inflammation (Inflammations) 01/2022 - 08/2002
27	Cytomegalovirus Retinitis 02/2017 - 01/2002
15	Panuveitis 11/2020 - 12/2006
13	Infections 01/2018 - 10/2002
12	Cataract (Cataracts) 01/2022 - 12/2003
11	Scleritis (Episcleritis) 01/2022 - 03/2004
9	Intermediate Uveitis (Chronic Cyclitis) 01/2018 - 10/2009
8	Macular Edema 01/2021 - 09/2011
8	Eye Diseases (Eye Disease) 01/2018 - 08/2005
7	Retinal Detachment (Retinal Detachments) 03/2016 - 12/2003
7	Bullous Pemphigoid (Pemphigoid) 03/2010 - 01/2004
6	Vision Disorders (Hemeralopia) 04/2022 - 04/2003
6	Posterior Uveitis 03/2020 - 03/2010
5	Anterior Uveitis 01/2022 - 11/2009
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2020 - 05/2007
4	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 09/2007
4	Birdshot Chorioretinopathy 01/2022 - 07/2005
4	Neoplasms (Cancer) 01/2018 - 01/2008
4	Hypertension (High Blood Pressure) 05/2017 - 09/2013
4	Opportunistic Infections (Opportunistic Infection) 04/2015 - 04/2007
3	Blindness (Hysterical Blindness) 04/2022 - 05/2007
3	Necrosis 01/2022 - 07/2009
3	Epiretinal Membrane (Epiretinal Membranes) 01/2017 - 05/2007
3	Spondylarthropathies 03/2014 - 02/2010
2	Band-Shaped Corneal Dystrophy 01/2022 - 11/2012
2	Disease Progression 12/2021 - 09/2004
2	Hyperlipidemias (Hyperlipidemia) 01/2019 - 05/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 05/2010
2	Choroidal Neovascularization 09/2007 - 12/2006
2	Conjunctivitis 09/2006 - 08/2003
2	HIV Infections (HIV Infection) 09/2005 - 09/2004
2	Neutropenia 10/2002 - 03/2002
1	Lyme Disease (Disease, Lyme) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Choroiditis 01/2021
1	Ocular Tuberculosis 01/2021
1	Glaucoma 11/2020
1	Acute Retinal Necrosis Syndrome 03/2020

Drug/Important Bio-Agent (IBA)

38	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 08/2005
23	Retinaldehyde (Retinal)IBA 03/2020 - 12/2002
18	SteroidsIBA 01/2021 - 08/2002
14	Prednisone (Sone)FDA LinkGeneric 04/2022 - 10/2003
12	Fluocinolone Acetonide (Capex)FDA LinkGeneric 11/2020 - 04/2010
8	AntimetabolitesIBA 12/2019 - 01/2008
8	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 08/2002
7	Pharmaceutical PreparationsIBA 01/2022 - 10/2002
7	Ganciclovir (Cytovene)FDA LinkGeneric 01/2019 - 04/2002
5	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 10/2008
5	Alkylating AgentsIBA 01/2018 - 08/2002
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2010
4	RNA (Ribonucleic Acid)IBA 04/2015 - 10/2002
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2010 - 08/2005
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2010 - 12/2008
4	Azathioprine (Imuran)FDA LinkGeneric 10/2009 - 10/2008
4	DNA (Deoxyribonucleic Acid)IBA 04/2006 - 04/2002
3	Cidofovir (Vistide)FDA Link 01/2019 - 02/2004
3	Monoclonal AntibodiesIBA 01/2019 - 04/2002
3	Calcineurin InhibitorsIBA 01/2018 - 12/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2010 - 08/2003
3	Matrix Metalloproteinases (MMPs)IBA 12/2008 - 01/2004
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	Fatty Acid-Binding ProteinsIBA 01/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	InterferonsIBA 01/2022 - 01/2019
2	InterleukinsIBA 01/2022 - 01/2019
2	Lipopolysaccharide ReceptorsIBA 01/2022 - 01/2019
2	Triamcinolone (Aristocort)FDA Link 01/2019 - 09/2007
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2019 - 09/2011
2	Adalimumab (Humira)FDA Link 06/2017 - 03/2014
2	Fluorescein (Funduscein)FDA LinkGeneric 11/2015 - 09/2007
2	Interleukin-10 (Interleukin 10)IBA 12/2013 - 08/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2013 - 12/2008
2	Silicone OilsIBA 11/2012 - 12/2003
2	AntibodiesIBA 07/2012 - 01/2004
2	Antiviral Agents (Antivirals)IBA 08/2010 - 08/2005
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 02/2010 - 02/2010
2	Foscarnet FDA LinkGeneric 01/2010 - 03/2003
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2009 - 03/2004
2	Filgrastim (Neupogen)FDA Link 10/2002 - 03/2002
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2002 - 03/2002
1	SolutionsIBA 04/2022
1	VaccinesIBA 12/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	KynurenineIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019

Therapy/Procedure

57	Therapeutics 01/2022 - 01/2002
32	Highly Active Antiretroviral Therapy (HAART) 02/2017 - 01/2002
7	Injections 01/2021 - 09/2011
5	Vitrectomy 01/2017 - 04/2012
4	Drug Therapy (Chemotherapy) 12/2008 - 12/2006
2	Phacoemulsification 11/2012 - 12/2003
1	Trabeculectomy (Trabeculoplasty) 01/2022
1	Transplantation 01/2022